Hot Chips - Stock Recommendations For Your Portfolio
5/17/2012 9:00 PM Thursday
DSIJ selects 2 aggressive stocks picks in every issue, with a 7-15 day horizon based upon the bullish trend during that period. For this issue, we are recommending companies from the IT and FMCG sectors.
GLENMARK PHARMA | BSE Code: 532296 | Volume: 200000 | CMP: Rs 348
Glenmark Pharmaceuticals reported a 34 per cent growth in sales and a 33 per cent growth in PAT for Q4FY12 on a YoY basis. The company profited from core sales growth in the specialty business in India and semi-regulated markets.
Its generics business benefited from the full impact of the dermatology portfolio and 12 new products in the US, new molecules in APIs as well as license income from the EU. A better flow of approvals in oral contraceptives (OC) and a strong portfolio of controlled release drugs helped the company achieve strong growth in the US sales. The focussed approach in key therapeutic areas has helped it to garner better growth in this segment too. The management’s strategy to keep a major part of its exports unhedged has paid off with USD/INR appreciation. The management has given a guidance of 22-25 per cent sales growth in the company’s core business, which also provides a positive bias to the stock. Capex and R&D are expected to touch Rs 250 crore in FY13. Investors can look at the scrip from a medium-term perspective.
|Last Seven Days’ Volume Table (No. Of Shares)|
|08-May-12 ||43262 |
|09-May-12 ||70134 |
|10-May-12 ||720240 |
|11-May-12 ||255388 |
|14-May-12 ||85847 |
|15-May-12 ||121854 |
|16-May-12 ||200000 |
Find More Articles on: DSIJ Magazine, Hot Chips, Stock Recommendations, Fundamental Picks, Product, Large Cap
«« First « Previous |1 2 | Next › Last ››